Shares of Sun Pharma bounced back on value-buying today, rising close to 4 per cent, in an overall bullish broader market.
The stock of the drug major ended the day 3.35 per cent higher at Rs 832.25 on BSE. During the day, it gained 3.63 per cent at Rs 834.60.
On NSE, the shares settled at Rs 834.55, up 3.63 per cent, from the previous close.
In line with the rally, the company's market valuation went up Rs 6,485.15 crore to Rs 2,00,269.60 crore.
The stock had received severe drubbing yesterday, falling a steep 15 per cent, after the drug maker said it expects to take a hit on profit for the fiscal due to charges related to the ongoing integration with Ranbaxy Laboratories.
As a part of the integration process with Ranbaxy, the company expects to incur certain integration charges in order to generate long-term synergies from this merger, Sun Pharma had said in a statement on Monday.
The company completed the USD 4 billion merger deal with Ranbaxy Laboratories in March this year.
